Articles dans des revues avec comité de lecture (182)
  1. 142. Mathurin, P., Moreno, C., Samuel, D., Dumortier, J., Salleron, J., Durand, F., Castel, H., Duhamel, A., Pageaux, G.-P., Leroy, V., Dharancy, S., Louvet, A., Boleslawski, E., Lucidi, V., Gustot, T., Francoz, C., Letoublon, C., Castaing, D., Belghiti, J., Donckier De Donceel, V., Pruvot, F.-R., & Duclos-Vallée, J.-C. (2011). Early liver transplantation for severe alcoholic hepatitis. The New England journal of medicine, 365(19), 1790-1800. doi:10.1056/NEJMoa1105703
  2. 143. Germanova, D., Lucidi, V., Buggenhout, A., Boon, N., Bourgeois, N., Degré, D., Gustot, T., Moreno, C., Bali, M. A., Brisbois, D., & Donckier De Donceel, V. (2011). Liver transplantation in cases of portal vein thrombosis in the recipient: a case report and review of the various options. Transplantation proceedings, 43(9), 3490-3492. doi:10.1016/j.transproceed.2011.09.036
  3. 144. Deltenre, P., Corouge, M., Canva, V., Castel, H., Wartel, F., Dharancy, S., Louvet, A., Lazrek, M., Moreno, C., Henrion, J., & Mathurin, P. (2011). Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin. Journal of hepatology, 55(5), 989-995. doi:10.1016/j.jhep.2011.02.014
  4. 145. Trepo, E., Gustot, T., Degré, D., Lemmers, A., Verset, L., Demetter, P., Ouziel, R., Quertinmont, E., Vercruysse, V., Amininejad, L., Deltenre, P., Le Moine, O., Devière, J., Franchimont, D., & Moreno, C. (2011). Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. Journal of hepatology, 55(4), 906-912. doi:10.1016/j.jhep.2011.01.028
  5. 146. Vos, B., Moreno, C., Nagy, N., Adler, M., Fery, F., Cnop, M., Vereerstraeten, P., & Devière, J. (2011). Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. Acta Gastro-Enterologica Belgica (English ed.), 74(3), 389-394.
  6. 147. Cheung, K.-J., Tilleman, K., Deforce, D., Colle, I., Moreno, C., Gustot, T., & Van Vlierberghe, H. (2011). Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C. European journal of gastroenterology & hepatology, 23(8), 701-710. doi:10.1097/MEG.0b013e3283471b74
  7. 148. Deltenre, P., Moreno, C., Tran, A., Ollivier, I., Provôt, F., Stanke, F., Lazrek, M., Castel, H., Canva, V., Louvet, A., Colin, M., Glowacki, F., Dharancy, S., Henrion, J., Hazzan, M., Noel, C., & Mathurin, P. (2011). Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy. Alimentary pharmacology & therapeutics, 34(4), 454-461. doi:10.1111/j.1365-2036.2011.04741.x
  8. 149. Trepo, E., Potthoff, A., Pradat, P., Bakshi, R., Young, B., Lagier, R., Moreno, C., Verset, L., Cross, R., Degré, D., Lemmers, A., Gustot, T., Berthillon, P., Rosenberg, W., Trepo, C., Sninsky, J., Adler, M., & Wedemeyer, H. (2011). Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease. Journal of hepatology, 55(1), 38-44. doi:10.1016/j.jhep.2010.10.018
  9. 150. Trepo, E., Pradat, P., Potthoff, A., Momozawa, Y., Quertinmont, E., Gustot, T., Lemmers, A., Berthillon, P., Amininejad, L., Chevallier, M., Schlué, J., Kreipe, H., Devière, J., Manns, M., Trepo, C., Sninsky, J., Wedemeyer, H., Franchimont, D., & Moreno, C. (2011). Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology, 54(1), 60-69. doi:10.1002/hep.24350
  10. 151. Orlent, H., Reynaert, H., Bourgeois, S., Dideberg, V., Adler, M., Colle, I., De Maeght, S., Laleman, W., Michielsen, P., Moreno, C., Mulkay, J.-P., Starkel, P., Delwaide, J., & Belgian Association for the Study of the Liver, (2011). IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use? Acta gastro-enterologica Belgica (Ed. multilingue), 74(2), 317-322.
  11. 152. Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., Ferenci, P., Nevens, F., Müllhaupt, B., Pockros, P., Terg, R., Shouval, D., van Hoek, B., Weiland, O., Van Heeswijk, R., De Meyer, S., Luo, D., Boogaerts, G., Polo, R., Picchio, G., Beumont, M., & Moreno, C. (2011). Telaprevir for retreatment of HCV infection. The New England journal of medicine, 364(25), 2417-2428. doi:10.1056/NEJMoa1013086
  12. 153. Trepo, E., Franchimont, D., & Moreno, C. (2011). Association of PNPLA3 (rs738409 C>G) with liver damage in liver diseases: One step closer to personalized medicine? Personalized medicine, 8, 595-597.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Suivant >>